1

SpiroVant’s SP‑101 AAV Gene Therapy Enters Inhalation Trials

 News Discuss 
SpiroVant is advancing SP‑101, an inhaled AAV vector carrying CFTR minigene, into early human studies—a major push in genetic-based CF treatments . https://www.datamintelligence.com/research-report/cystic-fibrosis-pipeline-insights-2025

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News